SURAKSHA

NSE:SURAKSHA India Diagnostics & Research
Market Cap
$28.29K
₹2.45 Million INR
Market Cap Rank
#43312 Global
#2112 in India
Share Price
₹256.30
Change (1 day)
+2.07%
52-Week Range
₹251.10 - ₹349.95
All Time High
₹349.95
About

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping… Read more

SURAKSHA - Asset Resilience Ratio

Latest as of September 2025: 10.91%

SURAKSHA (SURAKSHA) has an Asset Resilience Ratio of 10.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₹414.87 Million
Cash + Short-term Investments
Total Assets
₹3.80 Billion
All company assets
Resilience Assessment
Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how SURAKSHA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down SURAKSHA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₹0.00 0%
Short-term Investments ₹414.87 Million 10.91%
Total Liquid Assets ₹414.87 Million 10.91%

Asset Resilience Insights

  • Moderate Liquidity: SURAKSHA has 10.91% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

SURAKSHA Industry Peers by Asset Resilience Ratio

Compare SURAKSHA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF
Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860
Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for SURAKSHA (2021–2025)

The table below shows the annual Asset Resilience Ratio data for SURAKSHA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 5.35% ₹178.59 Million ₹3.34 Billion -10.99pp
2024-03-31 16.35% ₹490.76 Million ₹3.00 Billion -1.48pp
2023-03-31 17.82% ₹501.17 Million ₹2.81 Billion +2.62pp
2022-03-31 15.20% ₹419.50 Million ₹2.76 Billion +11.16pp
2021-03-31 4.04% ₹69.10 Million ₹1.71 Billion --
pp = percentage points